![](/img/cover-not-exists.png)
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Gold, Michael, Alderton, Claire, Zvartau-Hind, Marina, Egginton, Sally, Saunders, Ann M., Irizarry, Michael, Craft, Suzanne, Landreth, Gary, Linnamägi, Ülla, Sawchak, SharonVolume:
30
Year:
2010
Language:
english
Journal:
Dementia and Geriatric Cognitive Disorders
DOI:
10.1159/000318845
File:
PDF, 583 KB
english, 2010